# Study on Neuropsychiatric Behavior in Cadmium-exposed People

> **NCT06572566** · — · COMPLETED · sponsor: **Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.** · enrollment: 160 (actual)

## Conditions studied

- Cadmium Exceeds the Standard

## Interventions

- **OTHER:** Non-invasive examination and assessment.

## Key facts

- **NCT ID:** NCT06572566
- **Lead sponsor:** Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2024-01-08
- **Primary completion:** 2026-03-30
- **Final completion:** 2026-03-30
- **Target enrollment:** 160 (ACTUAL)
- **Last updated:** 2026-04-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06572566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06572566, "Study on Neuropsychiatric Behavior in Cadmium-exposed People". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06572566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
